Arca
Skip to content
Tools
Tools

Alcoholic hepatitis

Drug research and approvals for alcoholic hepatitis: what is recruiting, what Health Canada authorized, FDA orphan designations and EU medicines. See every condition.

As of Nov 21, 2026, 28 studies of alcoholic hepatitis are recruiting on ClinicalTrials.gov, Health Canada has authorized 2 drug trials for it since 2013, and FDA has 0 approved and 1 open orphan designations naming it.

  • Recruiting worldwide: 28
  • Trials authorized in Canada: 2
  • FDA orphan approvals: 0
  • EU medicines: 0

Recruiting now

Newest posted first, of 28 recruiting on ClinicalTrials.gov ↗

Drug pipeline

Each drug at the furthest stage it has reached for this condition, from ChEMBL's drug indications

Phase 3 5

Phase 2 12

Phase 1 or earlier 2

How its trials ended

102 ClinicalTrials.gov studies of the condition, classified by TrialPanorama, partly automatically, so some labels are wrong

Of the 24 whose ending is known, 13% met their primary endpoint, 29% missed it and 58% stopped early.

  • Completed, result not reported3635%
  • Ongoing2323%
  • Status unknown1919%
  • Missed its primary endpoint77%
  • Stopped: other or unclear55%
  • Met its primary endpoint33%
  • Stopped: lack of efficacy33%
  • Stopped: safety22%
  • Stopped: funding22%
  • Stopped: enrollment or feasibility11%
  • Stopped: sponsor or business decision11%

Trials authorized in Canada

Newest first; search them all in Canada trials
Feb 27, 2024A phase 1b multiple ascending dose study to assess the safety, tolerability and pharmacokinetics of SZN-043, in participants with severe alcohol-associated…SZN-043Surrozen Operating, Inc.Closed
Sep 8, 2016A phase 2, double-blind, randomized study evaluating the safety, tolerability, and efficacy of GS-4997 in combination with prednisolone versus prednisolone…GS-4997Gilead SciencesOngoing

FDA orphan designations

Approved first, then open designations, newest first
DateDrugSponsorStatus
Mar 18, 1994OxandroloneTreatment of moderate/severe acute alcoholic hepatitis in the presence of moderate protein calorie malnutrition.Bio-Technology General Corp.Designated

Condition names come from Health Canada's trial database. Orphan designations and EU medicines are matched when their indication names the condition as whole words, so a broader or differently worded indication can be missed. Recruiting counts are live from ClinicalTrials.gov's own condition search, refreshed daily. ClinicalTrials.gov, Health Canada Clinical Trials Database, FDA orphan designations, EMA

Esc

Type a name: a tool, a company, a drug or brand, a condition, a gene or a state. Identifiers like K231234, NCT05012345 or NDA 215866 open their record.

Logos are each company's own site icon, matched by name through Wikidata, or logos provided by Logo.dev.Company names and logos identify the companies in public FDA and registry records and do not imply endorsement.